A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio, Colleagues Call for Increased Focus on Reducing Maternal Mortality in the U.S.
Washington, D.C. – U.S. Senator Marco Rubio (R-FL) today joined Senators Tom Carper (D-DE), Shelley Moore Capito (R-WV), Bill Nelson (D-FL), and Tim Scott (R-SC) in calling for an increased focus on reducing maternal mortality in the United States and improving health outcomes for all mothers and children. In a letter to Health and Human Services Secretary Alex Azar and Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma, 14 Republican and Democratic senators requested that the Department and Agency prioritize developing strategies to reduce maternal mortality rates, including for pregnant women and mothers enrolled in Medicaid and the Children’s Health Insurance Program (CHIP).
Specifically, they highlighted the racial and ethnic disparities in maternal and infant health in the United States and requested additional information about what the Administration is currently doing to reduce infant and maternal mortality rates, and what some providers have done to improve health outcomes.
The senators were also joined by Senators Dean Heller (R-NV), Ron Wyden (D-OR), Lisa Murkowski (R-AL), Ben Cardin (D-MD), Todd Young (R-IN), Cory Booker (D-NJ), Debbie Stabenow (D-MI), Robert Menendez (D-NJ), Joe Donnelly (D-IN).
The text of the letter is below.
Dear Secretary Azar and Administrator Verma:
From 2000 to 2014, the rate of maternal mortality, defined as the death of a woman while pregnant or during the one-year period following the date of the end of pregnancy, increased by 26 percent in the United States. This troubling trend makes the United States an outlier among every other developed country. We write to you to request that your Department and Agency focus on strategies to reduce maternal mortality rates in the United States, including for pregnant women and mothers enrolled in Medicaid and the Children’s Health Insurance Program (CHIP).
Racial and ethnic disparities in maternal and infant health are especially of concern. African-American women are three to four times more likely to die from pregnancy-related causes as compared to other women in the United States. The mortality rate among African-American infants is more than two times higher than other infants. American Indian and Alaskan Native women also fare worse than white women with approximately twice as many pregnancy-related deaths per 100,000 live births. Research indicates that numerous factors may contribute to these glaring health disparities, including barriers to accessing necessary pre- and post-natal care, a growing prevalence of chronic conditions, maternal stress, inadequate training for health care providers, racial bias, and social determinants of health. We therefore also ask that you review existing data and provide us with recommendations about what can be done at the federal, state, and local levels to reduce mortality and improve health outcomes for all mothers and their children, regardless of their racial and ethnic background, income level, or educational attainment.
The frustration and urgency over the high rate of maternal mortality is compounded by research determining that roughly 60 percent of maternal deaths in the United States could be prevented through improvements for individual patient care and education, standardized protocols, and timely interventions. Moreover, the Agency for Healthcare Research and Quality determined that severe maternal mortality rates may be higher in some hospitals compared to others, indicating that some hospitals have developed ways to better prepare for pregnancy-related complications that could be adopted nationwide. Although some states have taken significant steps to overcome training, education, and system barriers to reducing maternal mortality, not all hospitals and birth centers have implemented common protocols and comprehensive quality measures to help ensure safe labor and delivery, prenatal and postnatal care. Where protocols exist, they may not be integrated into health care delivery systems and hospitals; systems of accountability and support for patients and clinicians are often lacking. Furthermore, programs to address the social determinants of health beyond the clinic can sometimes be important to ensure that women are getting the care they need, when they need it.
With these challenges in mind, we ask that you respond to the questions below by November 1, 2018:
We thank you for your attention to these important matters and we look forward to working with you to ensure the health of all mothers and their newborn children.
Sincerely,
###